Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Endovascular Therapy is Scopus-indexed (Q1, CiteScore 4.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1526-6028Verify ISSN ↗1545-1550Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: About US$4,400 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 101 / 597 | 83rd | Q1 |
| Radiology, Nuclear Medicine and Imaging | 106 / 361 | 70th | Q2 |
| Cardiology and Cardiovascular Medicine | 124 / 409 | 69th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q1, CiteScore 4.5.
Journal of Endovascular Therapy is Q1 in Surgery (rank 101 of 597), Q2 in Radiology, Nuclear Medicine and Imaging (rank 106 of 361) and Q2 in Cardiology and Cardiovascular Medicine (rank 124 of 409), by CiteScore 2025.
Journal of Endovascular Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.5, which places it in quartile Q1 at the 83rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.757, quartile Q1, with an H-index of 113.
The publisher lists an article processing charge of about US$4,400 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Endovascular Therapy is published by SAGE Publications Inc. Its print ISSN is 1526-6028 and its online ISSN is 1545-1550.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Endovascular Therapy has an h-index of 109 and a 2-year mean of 1.81 citations per paper (OpenAlex). Its Scopus CiteScore is 4.5, quartile Q1. On 2-year citations it ranks #146 of 585 Scopus journals in Surgery.
Journal of Endovascular Therapy published 208 papers in 2025; its busiest recent year was 2023 with 255. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (18.7%), Japan (16.1%) and Italy (10.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.